On linear regression, a positive trend was suggested between the length of GnRH-agonist administration and an increase in the serum cholesterol level, with a correlation coefficient of 0.16 and a P value of 0.052 ( Fig. 3 ).
← all excerpts
Serum Cholesterol Level Changes during Gonadotropin-Releasing Hormone-Agonist Therapy in Premenopausal Female Patients with Breast Cancer.
1
—
—